These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3032664)

  • 21. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP; Salach JI; Crabtree D
    Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress.
    Lambert CE; Bondy SC
    Life Sci; 1989; 44(18):1277-84. PubMed ID: 2785626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
    Lee EH
    Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Felbamate decreases synaptic transmission in the CA1 region of rat hippocampal slices.
    Pugliese AM; Passani MB; Pepeu G; Corradetti R
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1100-8. PubMed ID: 8968330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Barbeau A; Dallaire L; Buu NT; Veilleux F; Boyer H; de Lanney LE; Irwin I; Langston EB; Langston JW
    Life Sci; 1985 Mar; 36(11):1125-34. PubMed ID: 3871891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
    Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
    J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
    Riachi NJ; LaManna JC; Harik SI
    J Pharmacol Exp Ther; 1989 Jun; 249(3):744-8. PubMed ID: 2786562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
    Mizuno Y; Sone N; Saitoh T
    J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropharmacological manipulations with MPTP.
    Barnes NJ; Bradbury AJ; Costall B; Domeney AM; Kelly ME; Naylor RJ
    J Neural Transm Suppl; 1986; 20():47-63. PubMed ID: 3091761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD; Ramirez VD
    Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S; Vincent SR
    Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates.
    Ríos C; Tapia R
    Neurosci Lett; 1987 Jun; 77(3):321-6. PubMed ID: 3497366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats.
    Hollrigel GS; Chen K; Baram TZ; Soltesz I
    Neuroscience; 1998 May; 84(1):71-9. PubMed ID: 9522363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylmercury acts at multiple sites to block hippocampal synaptic transmission.
    Yuan Y; Atchison WD
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1308-16. PubMed ID: 8531097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MPDP+ causes a non-reversible decrease in neostriatal synaptic transmission in mouse brain slice.
    Wilson JA; Wilson JS; Weight FF
    Brain Res; 1987 Nov; 425(2):376-9. PubMed ID: 2827846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors.
    Zhu G; Huang Y; Chen Y; Zhuang Y; Behnisch T
    J Neurochem; 2012 Aug; 122(3):582-93. PubMed ID: 22651101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.